Clinical Trials Logo

Lung Diseases clinical trials

View clinical trials related to Lung Diseases.

Filter by:

NCT ID: NCT00051792 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

Yoga for Treating Shortness of Breath in Chronic Obstructive Pulmonary Disease (COPD)

Start date: January 2003
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness of yoga in reducing shortness of breath in people with chronic obstructive pulmonary disease (COPD). Patients in this study must have moderate to severe COPD and be primarily limited by shortness of breath.

NCT ID: NCT00051363 Completed - Sleep Clinical Trials

Apnea Positive Pressure Long-Term Efficacy Study

APPLES
Start date: September 2002
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the effectiveness of nasal continuous positive airway pressure (CPAP) therapy for the treatment of obstructive sleep apnea syndrome (OSAS).

NCT ID: NCT00046670 Completed - Lung Diseases Clinical Trials

Sleep Disordered Breathing, APOE, and Lipid Metabolism

Start date: September 2002
Phase: N/A
Study type: Observational

To examine the relationship between obstructive sleep apnea and lipid metabolism.

NCT ID: NCT00046644 Completed - Asthma Clinical Trials

Leukotriene Polymorphisms and Montelukast Response - Ancillary to LoDo Trial

Start date: June 2002
Phase: N/A
Study type: Observational

To elucidate the mechanisms underlying inter-patient variation in response to montelukast, a drug for asthma.

NCT ID: NCT00041860 Completed - Cancer Clinical Trials

Modulation of Benzene Metabolism by Exposure to Environment

Start date: n/a
Phase: N/A
Study type: Interventional

The research is to evaluate benzene metabolism after exposure at levels that can be found in the environment, such as the higher end concentrations in the air inside cars and buses while being driven in heavy traffic and inside private and public parking garages. To do so breath, urine, and blood samples prior to, during and after being exposed to benzene as well as benzene levels and benzene metabolites present are measured.

NCT ID: NCT00041574 Terminated - Sickle Cell Disease Clinical Trials

Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric Oxide

Start date: April 2002
Phase: Phase 2
Study type: Interventional

The purpose of this program is to evaluate the logistic issues and patient requirements for chronic pulsed INOmax delivery in ambulatory, home-care patients. To understand patient needs, patients with a variety of underlying diseases will be included. Safety of chronic therapy will be monitored by serial measurements of methemoglobin, platelet function assay and reported adverse events.

NCT ID: NCT00041548 Terminated - Hypoxemia Clinical Trials

Inhaled Nitric Oxide in Neonates With Elevated A-a DO2 Gradients Not Requiring Mechanical Ventilation

Start date: May 2002
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this pilot study is to evaluate whether administration of nitric oxide (NO)gas by oxygen hood at 20 ppm significantly increases PaO2, as compared to placebo gas (oxygen), within one hour of initiation and with no significant adverse effects.

NCT ID: NCT00037778 Completed - Cystic Fibrosis Clinical Trials

Genetic Modifiers of Cystic Fibrosis: Sibling Study

Start date: September 2001
Phase: N/A
Study type: Observational

The purpose of this study is to identify modifier genes in cystic fibrosis (CF).

NCT ID: NCT00037765 Active, not recruiting - Cystic Fibrosis Clinical Trials

Gene Modifiers of Cystic Fibrosis Lung Disease

Start date: September 2001
Phase:
Study type: Observational

The purpose of this study is to examine genetic modifiers of the severity of cystic fibrosis lung disease.

NCT ID: NCT00037739 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease Gene Localization

Start date: April 2001
Phase: N/A
Study type: Observational

To localize within the genome a chronic obstructive pulmonary disease susceptibility gene.